Vertex Pharmaceuticals Incorporated VRTX

VRTX Company Overview

Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on discovering, developing, and commercializing innovative medicines for serious diseases. The company operates primarily within the biotechnology and pharmaceutical industries, with a strong emphasis on genetic and rare diseases. Vertex’s business model centers on developing transformative therapies that address the underlying causes of disease rather than symptomatic treatment.

Vertex is best known for its leadership in treatments for cystic fibrosis (CF), where it has developed multiple approved therapies that have reshaped the standard of care. Its primary revenue drivers are CF modulators, alongside a growing pipeline targeting pain, sickle cell disease, beta thalassemia, and type 1 diabetes. Founded in 1989, Vertex evolved from a research-focused biotech into a profitable, fully integrated pharmaceutical company following the commercial success of its CF franchise in the 2010s.